Shouxiangu and Partners Jointly Establish Cell and Gene Venture Capital Partnership

证券时报··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Shouxiangu and partners have jointly funded the establishment of Hangzhou Huarui Cell and Gene Venture Capital Partnership, a limited partnership, which was recently incorporated. According to Qichacha APP, the partnership's business scope includes venture capital investment, limited to investing in unlisted companies, as well as equity investment. Qichacha equity penetration shows that the enterprise is jointly funded by Shouxiangu and others.

Impact on assets 1

Others▲ · 1 stocks
Zhejiang Shouxiangu Pharm Co
603896
▲ PositiveCapitalrelevance

Shouxiangu jointly funded and established Hangzhou Huarui Cell and Gene Venture Capital Partnership, a venture capital investment vehicle.

Off-coverage companies 1

杭州华睿细胞与基因创业投资合伙企业（有限合伙）Private± Mixed
relevance

© 2026 MarketIVNews